An R75W mutation in the gap junction β2 (GJB2) gene causes severe fragmentation of gap junction plaques, connecting adjacent ...

Recent research has revealed that nitisinone, a drug originally used to treat rare genetic conditions, can fatally disrupt a ...

Epicrispr Biotechnologies, a biotechnology company focused on developing curative therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational ...

R75W mutation in the gap junction β2 (GJB2) gene causes severe fragmentation of gap junction plaques, connecting adjacent ...

Ultimately, privacy isn't something we can get by installing a particular browser—it's more of a mindset, and it includes ...

A new study published in the Journal of Geo-information Science explores the spatio-temporal patterns of taxi operations in Xiamen, China, using a ...

Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...

Understanding the spatio-temporal patterns of taxi operations is crucial for urban transport planning and management. A ...

In late January, OpenAI and SoftBank announced Stargate, a four-year U.S. artificial intelligence infrastructure project ...

Nitisinone, a drug for genetic disorders, could help control malaria by making human blood toxic to mosquitoes. Anopheles ...

Nitisinone, a drug for rare diseases, kills mosquitoes when present in human blood and may become a new tool to fight malaria ...

A new drug called nitisinone, which makes human blood poisonous to mosquitoes, could be a vital new tool to fight malaria.